Cullgen Stock / BioTech & PharmaFounded: 2018Funding to Date: $116MM

Cullgen, founded in 2018, is a biopharmaceutical company that develops new chemical entities (NCEs) designed to treat diseases that lack effective therapeutic approaches. Using its proprietary uSMITE™ platform, the company expands on the drug design paradigm aiming to target proteins that are typically resistant to treatments for selective destruction. Cullgen has produced several highly potent, selective, and bioavailable targeted protein degrader compounds. Cullgen is headquartered in San Diego, California.

Register To Buy and Sell Shares

For more details on financing and valuation for Cullgen, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Cullgen’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Cullgen.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Cullgen investors also invested in these private companies

Shenzhen Investment
Sincere Capital
Sirius Holding Group
Voyagers Capital
GNI Group
South China Venture Capital
Highlight Capital
Heights Capital Management
3E Bioventures Capital
Wuxi Capital Group


Management Team

Thomas Eastling
Chief Financial Officer
Yue Xiong Ph.D
Co-Founder & Chief Scientific Officer
Jian Jin Ph.D
Ying Luo Ph.D
Co-Founder, Chief Executive Officer & President

Board Members

Cuiping Gu Ph.D
Sequoia Capital China

Frequently Asked Questions About Cullgen’s Stock

Can you buy Cullgen’s stock?
Cullgen is not publicly traded on NYSE or NASDAQ in the U.S. To buy Cullgen’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Cullgen’s stock?
Yes, you can sell stock of a private company like Cullgen. Forge can help you sell your Cullgen stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Cullgen’s stock price?
Cullgen is a privately held company and therefore does not have a public stock price. However, you may access Cullgen’s private market stock price with Forge Data.
What is Cullgen’s stock ticker symbol?
Cullgen does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Cullgen Raises $40 Million in New Financing Led by AstraZeneca-CICC Fund
Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of targeted protein degradation technology, today announced that it has raised $40 million in new financing.
Updated on: Jun 16, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.